Invention Grant
- Patent Title: Bipyrazole derivatives as JAK inhibitors
- Patent Title (中): 吡咯类衍生物作为JAK抑制剂
-
Application No.: US14279929Application Date: 2014-05-16
-
Publication No.: US09382231B2Publication Date: 2016-07-05
- Inventor: Yun-Long Li , Jincong Zhuo , Ding-Quan Qian , Song Mei
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D403/14
- IPC: C07D403/14
Abstract:
The present invention provides compounds of Formula I: or pharmaceutically acceptable salts thereof, as well as their compositions and methods of use, that inhibit the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Public/Granted literature
- US20140343030A1 BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS Public/Granted day:2014-11-20
Information query
